SweetWater Brewing and Zoo Atlanta Celebrate 18 Years of Collaboration with a Special Edition Beer

SweetWater Brewing and Zoo Atlanta Celebrate 18 Years of Collaboration with a Special Edition Beer Introducing 'Pink Flamboyance Lager' – A Tribute to Zoo Atlanta's Iconic Flamingos GlobeNewswire May 29, 2025 ATLANTA, May 29, 2025 (GLOBE NEWSWIRE) — SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the largest craft brewer in the Southeast and a Tilray […]

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference GlobeNewswire May 29, 2025 PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that the Company will participate

New study shows significant decline in men’s mental health; half lack sufficient social support

New study shows significant decline in men's mental health; half lack sufficient social support GlobeNewswire May 29, 2025 Stress and depression risk increase for Canadian men One in two men lack sufficient social support networks Canadian Men's Health Foundation launches #NeverAlone campaign for Men's Health Month in June VANCOUVER, British Columbia, May 29, 2025 (GLOBE

Replimune to Present at the 2025 Jefferies Global Healthcare Conference

Replimune to Present at the 2025 Jefferies Global Healthcare Conference GlobeNewswire May 29, 2025 WOBURN, Mass., May 29, 2025 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that members of the Replimune management team will present in a fireside chat at

Cocrystal Pharma’s Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain

Cocrystal Pharma's Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain GlobeNewswire May 29, 2025 CC-42344 was shown to be highly active against the highly pathogenic 2024 Texas H5N1 avian influenza strain The Company's virology study further confirmed the previous structural and in vitro data that revealed

Whitetail Properties Partners With Acres.com to Expand Marketing Efforts Nationwide

Whitetail Properties Partners With Acres.com to Expand Marketing Efforts Nationwide GlobeNewswire May 29, 2025 Fayetteville, Ark., May 29, 2025 (GLOBE NEWSWIRE) — Acres.com, the complete land intelligence platform, announced its new partnership with Whitetail Properties, a national land brokerage with agents across the country. Today, many Whitetail Properties Land Specialists use Acres' data and tools

BriteCore Named a Top 25 InsurTech Company of 2025 by The Financial Technology Report

BriteCore Named a Top 25 InsurTech Company of 2025 by The Financial Technology Report Recognition Underscores BriteCore's Innovation and Impact in the P&C Insurance Sector GlobeNewswire May 29, 2025 San Mateo, CA, May 29, 2025 (GLOBE NEWSWIRE) — BriteCore, a leading provider of cloud-native core systems for property and casualty (P&C) insurers, today announced that

Spectral AI Announces Voting Results from 2025 Annual Meeting of Stockholders

Spectral AI Announces Voting Results from 2025 Annual Meeting of Stockholders GlobeNewswire May 29, 2025 DALLAS, May 29, 2025 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announced results from its

Beghou Consulting Adds New Partners to Strengthen Market Access, Cell & Gene Therapy, and Technology Capabilities

Beghou Consulting Adds New Partners to Strengthen Market Access, Cell & Gene Therapy, and Technology Capabilities These latest partner additions extend Beghou's proven track record in adding top talent and investing in new technology to remain agile and responsive to both client and market needs GlobeNewswire May 29, 2025 EVANSTON, Ill., May 29, 2025 (GLOBE

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference GlobeNewswire May 29, 2025 WALTHAM, Mass. and BOULDER, Colo., May 29, 2025 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced its presentation at the Jefferies Global Healthcare Conference on Thursday, June

Scroll to Top